Editorial: Managing cancer metastasis by tackling anticancer drug resistance

• Erxi Wu,
• Erxi Wu,
• Erxi Wu,
• Erxi Wu,
• Erxi Wu,
• Zhongzhi Wu,
• Chao-Yie Yang,
• Dan Qi,
• Dan Qi,
• Xiaoxiao Hu,
• Xiaoxiao Hu,
• Xiaoxiao Hu,
• Xiaoxiao Hu,
• Wei Li

Affiliations

Erxi Wu

Department of Neurosurgery and Neuroscience Institute, Baylor Scott & White Health, Temple, TX, United States

Erxi Wu

Department of Neurosurgery, Baylor College of Medicine, Temple, TX, United States

Erxi Wu

School of Medicine, Texas A&M University, College Station, TX, United States

Erxi Wu

Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, TX, United States

Erxi Wu

LIVESTRONG Cancer Institutes and Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, United States

Zhongzhi Wu

Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States

Chao-Yie Yang

Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States

Dan Qi

Department of Neurosurgery and Neuroscience Institute, Baylor Scott & White Health, Temple, TX, United States

Dan Qi

Department of Neurosurgery, Baylor College of Medicine, Temple, TX, United States

Xiaoxiao Hu

State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Molecular Science and Biomedicine Laboratory and Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, China

Xiaoxiao Hu

Shenzhen Research Institute, Hunan University, Shenzhen, China

Xiaoxiao Hu

Innovation Institute of Industrial Design and Machine Intelligence, Quanzhou-Hunan University, Quanzhou, China

Xiaoxiao Hu

0Research Institute of Hunan University in Chongqing, Chongqing, China

Wei Li

Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, United States